Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC

Nature Genetics

Volumn 42, Issue 7, 2010, Pages 614-618

  Quan, Cheng ^a   Ren, Yun Qing ^a   Xiang, Lei Hong ^b   Sun, Liang Dan ^a   Xu, Ai E ^a,c   Gao, Xing Hua ^d   Chen, Hong Duo ^d   Pu, Xiong Ming ^a,e   Wu, Ri Na ^f   Liang, Chao Zhao ^a   Li, Jia Bin ^a   Gao, Tian Wen ^g   Zhang, Jian Zhong ^h   Wang, Xiu Li ^a,i   Wang, Jun ^j   Yang, Rong Ya ^a,k   Liang, Ling ^l   Yu, Jian Bin ^m   Zuo, Xian Bo ^a   Zhang, Sheng Quan ^a   Zhang, Shu Mei ^a   Chen, Gang ^a   Zheng, Xiao Dong ^a   Li, Pan ^a   Zhu, Jun ^a   Li, Yong Wei ^a,c   Wei, Xiao Dong ^a,c   Hong, Wei Song ^a,c   Ye, Ying ^b   Zhang, Yong ^b   Wu, Wei Su ^d   Cheng, Hui ^a   Dong, Pu Ling ^a   Hu, Da Yan ^a   Li, Yang ^a   Li, Min ^a   Zhang, Xin ^a   Tang, Hua Yang ^a   Tang, Xian Fa ^a   Xu, Sheng Xin ^a   He, Su Min ^a   Lv, Yong Mei ^a   Shen, Min ⁿ   Jiang, Hong Quan ⁿ   Wang, Ying ⁿ   Li, Kai ^g   Kang, Xiao Jing ^a,e   Liu, Yu Qin ^a,e   San, Li ^f   Liu, Zhi Fang ^f   Xie, Shao Qiong ^a,i   Zhu, Cheng Yao ^a   Xu, Qiang ^a   Gao, Jin Ping ^a   Hu, Wen Long ^a   Ni, Cheng ^a   Pan, Ting Meng ^a   Li, Yun ^a   Yao, Sha ^a   He, Cai Feng ^a   Liu, Yang Sheng ^a   Yu, Ze Ying ^a   Yin, Xian Yong ^a   Zhang, Feng Yu ^a   Yang, Sen ^a   Zhang, Xue Jun ^a,b   more..

^a ANHUI MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c THE THIRD PEOPLE S HOSPITAL OF HANGZHOU   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e PEOPLE S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION   (China)

^f INNER MONGOLIA MEDICAL COLLEGE   (China)

^g FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^h PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

ⁱ STD Hospital   (China)

^j WANNAN MEDICAL COLLEGE   (China)

^k CHINESE PLA GENERAL HOSPITAL   (China)

^l GUANGXI MEDICAL UNIVERSITY   (China)

^m THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

ⁿ CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ARTICLE; CASE CONTROL STUDY; CCR6 GENE; CHINESE; CHROMOSOME 6Q; CONTROLLED STUDY; FEMALE; FGFR1OP GENE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; RNASET2 GENE; VITILIGO;

ADOLESCENT; ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; VITILIGO; YOUNG ADULT;

EID: 77954143766     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.603     Document Type: Article

References (47)

1. Hann, S.K. & Nordlund, J.J. Vitiligo (Blackwell Science, Oxford, UK, 2000).
2. Das, S.K., Majumder, P.P., Chakraborty, R., Majumdar, T.K. & Haldar, B. Studies on vitiligo. I. Epidemiological profle in Calcutta, India. Genet. Epidemiol. 2, 71-78 (1985).
3. Birlea, S.A., Fain, P.R. & Spritz, R.A. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch. Dermatol. 144, 310-316 (2008).
4. Taïeb, A. & Picardo, M. Clinical practice. Vitiligo. N. Engl. J. Med. 360, 160-169 (2009).
5. Porter, J., Beuf, A.H., Nordlund, J.J. & Lerner, A.B. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen. Hosp. Psychiatry 1, 73-77 (1979).
6. Alkhateeb, A., Fain, P.R., Thody, A., Bennett, D.C. & Spritz, R.A. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16, 208-214 (2003).
7. Dell'anna, M.L. & Picardo, M. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res. 19, 406-411 (2006).
8. Spritz, R.A. The genetics of generalized vitiligo. Curr. Dir. Autoimmun. 10, 244-257 (2008).
9. Zhang, X.J. et al. Characteristics of genetic epidemiology and genetic models for vitiligo. J. Am. Acad. Dermatol. 51, 383-390 (2004).
10. Nath, S.K. et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am. J. Hum. Genet. 69, 1401-1406 (2001).
11. Alkhateeb, A. et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum. Mol. Genet. 11, 661-667 (2002).
12. Spritz, R.A., Gowan, K., Bennett, D.C. & Fain, P.R. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confrmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am. J. Hum. Genet. 74, 188-191 (2004).
13. Chen, J.J. et al. A novel linkage to generalized vitiligo on 4q13-q21 identifed in a genomewide linkage analysis of Chinese families. Am. J. Hum. Genet. 76, 1057-1065 (2005).
14. Jin, Y. et al. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 1216-1225 (2007).
15. Ren, Y. et al. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet. 5, e1000523 (2009).
16. Jin, Y., Birlea, S.A., Fain, P.R. & Spritz, R.A. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J. Invest. Dermatol. 127, 2558-2562 (2007).
17. Zamani, M. et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br. J. Dermatol. 145, 90-94 (2001).
18. Arcos-Burgos, M. et al. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum. Genet. 110, 334-342 (2002).
19. Jin, Y. et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N. Engl. J. Med. 362, 1686-1697 (2010).
20. Liu, J.B. et al. Association of vitiligo with HLA-A2: a meta-analysis. J. Eur. Acad. Dermatol. Venereol. 21, 205-213 (2007).
21. Zhang, X.J. et al. Association of HLA class I alleles with vitiligo in Chinese Hans. J. Dermatol. Sci. 35, 165-168 (2004).
22. Taştan, H.B., Akar, A., Orkunoglu, F.E., Arca, E. & Inal, A. Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res. 17, 181-184 (2004).
23. Han, J.W. et al. Genome-wide association study in a Chinese Han population identifes nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234-1237 (2009).
24. Zhang, X.J. et al. Psoriasis genome-wide association study identifes susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 41, 205-210 (2009).
25. Zhang, F.R. et al. Genomewide association study of leprosy. N. Engl. J. Med. 361, 2609-2618 (2009).
26. Campomenosi, P. et al. Characterization of RNASET2, the frst human member of the Rh/T2/S family of glycoproteins. Arch. Biochem. Biophys. 449, 17-26 (2006).
27. Acquati, F. et al. Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene 20, 980-988 (2001).
28. Monti, L. et al. RNASET2 as a tumor antagonizing gene in a melanoma cancer model. Oncol. Res. 17, 69-74 (2008).
29. Thompson, D.M. & Parker, R. The RNase Rny1p cleaves tRNAs and promotes cell death during oxidative stress in Saccharomyces cerevisiae. J. Cell Biol. 185, 43-50 (2009).
30. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J. Investig. Dermatol. Symp. Proc. 4, 91-96 (1999).
31. Mikolajka, A. et al. Structure of the N-terminal domain of the FOP (FGFR1OP) protein and implications for its dimerization and centrosomal localization. J. Mol. Biol. 359, 863-875 (2006).
32. Popovici, C. et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fbroblast growth factor receptor 1. Blood 93, 1381-1389 (1999).
33. Acquaviva, C. et al. The centrosomal FOP protein is required for cell cycle progression and survival. Cell Cycle 8, 1217-1227 (2009).
34. Schutyser, E., Struyf, S. & Van Damme, J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409-426 (2003).
35. + T cell crosspriming in vivo. Immunity 24, 191-201 (2006).
36. Birlea, S.A., Gowan, K., Fain, P.R. & Spritz, R.A. Genome-wide association study of generalized vitiligo in an isolated European founder population identifes SMOC2, in close proximity to IDDM8. J. Invest. Dermatol. 130, 798-803 (2010).
37. Barrett, J.C. et al. Genome-wide association defnes more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
38. Levy, C. et al. Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3. Blood 107, 2839-2845 (2006).
39. Garraway, L.A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplifed in malignant melanoma. Nature 436, 117-122 (2005).
40. Imielinski, M. et al. Common variants at fve new loci associated with early-onset infammatory bowel disease. Nat. Genet. 41, 1335-1340 (2009).
41. Zhang, Z. et al. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch. Dermatol. Res. 301, 167-173 (2009).
42. Taïeb, A. & Picardo, M. The defnition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 20, 27-35 (2007).
43. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
44. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719-748 (1959).
45. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
46. de Bakker, P.I. et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38, 1166-1172 (2006).
47. Browning, S.R. & Browning, B.L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81, 1084-1097 (2007).